Basic Information
Bioprojet is a drug development company founded in 1982 by Jeanne Leconte Marie, Jean-Charles Schwartz, and some pharmaceutical and medical doctors. Bioprojet pursues one goal: to design and develop drugs based on original works of fundamental research, which will be the first in a new therapeutic class. To achieve this goal, Bioprojet collaborates with Inserm, where Jean-Charles Schwartz leads a department, as well as therapeutic chemistry laboratories at various universities.